Status:
UNKNOWN
Performance of Novel Simplified Score for Chronic Hepatitis B Treatment Eligibility in Thailand
Lead Sponsor:
Mahidol University
Conditions:
Chronic Hepatitis B
Eligibility:
All Genders
18-80 years
Brief Summary
International and national guideline for chronic hepatitis B (HBV) infection treatment recommend initiated antiviral in high HBV viral loads patients with significant liver inflammation and significan...
Detailed Description
According to WHO Global health sector strategy on viral hepatitis 2016- 2021, WHO aim to global eliminate HBV infection within 2030. Main strategies for achievement are effective prevention and treatm...
Eligibility Criteria
Inclusion
- Treatment naive chronic hepatitis B infection patients who visited at liver clinic and internal medicine clinic Siriraj hospital during January 2015-December 2021
- Age \> 18 years
Exclusion
- Treatment experience chronic hepatitis B infection patients
- HIV co-infection
- HCV (hepatitis C) co-infection
- concomitant HCC (hepatocellular carcinoma)
- Pregnancy
- Incomplete data
Key Trial Info
Start Date :
April 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05295914
Start Date
April 10 2022
End Date
May 30 2022
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj Hospital
Bangkok, Thailand, 10700